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Abstract

Research has shown bacterial vaginosis to be one of the most common vaginal disorders
in women of child bearing age (Chen, Tian, & Beigi, 2009; Centers for Disease Control,
2012; Menard, 2011). Each year many women are seen by their gynecologist, sexually
transmitted infection (STI) clinics, and emergency rooms (ER) for complaints of having
malodorous discharge (Bradshaw, et al., 2005). Several STI’s and adverse pregnancy
outcomes have been attributed to women having bacterial vaginosis (Bradshaw, et al,
2005; Chen, et al.2009; Elkins, & Mayeaux, 2010). Women are predisposed to bacterial
vaginosis by the use of wearing non cotton underwear, douching, having multiple sex
partners, not using condoms, or not adhering to or complying with the recommended
treatment regimens. Each year non- adherence to medications cost the US billions of
dollars.

Purpose
This project was to (a) evaluate patients’ knowledge regarding bacterial vaginosis
prevention and treatment regimens, (b) and attempt to increase patients’ knowledge as a
result of training of providers.
Methods
A quasi-experimental approach was utilized using a comparative change model at
two different Planned Parenthood health centers. The project was conducted Monday
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through Saturday enrolling 50 women diagnosed with bacterial vaginosis. One clinic was
randomly selected for providers to receive the 45 minute in-service training, and the other
clinic’s providers did not receive the in-service training. Subjects were asked to complete
two surveys. The first survey consisted of 6 questions which were administered after
their diagnosis for bacterial vaginosis and consent obtained which took no longer than 34 minutes to complete. Nine to 14 days after the initial visit a second survey was
administered by phone by the researcher and assistants.
Results

The intervention group has a lower median adherence score compared to the
control group (p<.002) which indicates that the intervention group has better adherence to
their Flagyl and Metro Gel medication.

Adherence of wearing thong and cotton underwear was assessed as a yes/no
variable by intervention status using Fisher’s Exact Test instead of Pearson’s Chi-Square
given small cell size.

There was no significant difference between the intervention and control group
(p>0.05) in regards to thong or cotton underwear adherence.

Conclusion
There was an increase in patients’ knowledge regarding adhering to treatment
regimens; however, there were no significant change in behavior.
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Introduction
Research has shown bacterial vaginosis to be one of the most common vaginal
disorders in women of child bearing age (Chen, Tian, & Beigi, 2009; Centers for Disease
Control, 2012; Menard, 2011). Each year many women are seen by their gynecologist,
sexually transmitted infection (STI) clinics, and emergency rooms (ER) for complaints of
having malodorous discharge (Bradshaw, et al., 2005). Several STI’s and adverse
pregnancy outcomes has been attributed to women having bacterial vaginosis (Bradshaw,
et al, 2005; Chen, et al.2009; Elkins, & Mayeaux, 2010). The etiology of bacterial
vaginosis continues to be misunderstood. Approximately 45% of all women seen and
diagnosed with symptomatic abnormal vaginal discharges are due to this clinically mild
disease. Koumans, Sternberg, Bruce, McQuillan, Kendrick, Sutton, & Markowitz, 2007;
Menard, 2011; Elkins & Mayeaux, 2010 have stated that many women self- medicate
their vaginal discharge with anti-fungal medications.

Statement of Purpose
The purpose of this project was to evaluate patients’ knowledge regarding
bacterial vaginosis prevention and treatment regimens, and attempt to increase patients’
knowledge as a result of training of providers. Specifically, there will be a greater effect
on the intervention group receiving education from the health care providers who have
received additional in-servicing regarding bacterial vaginosis compared with standard
patient care with patients receiving discharge instructions from the educators or nurse
practitioner but who have not received additional training.
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Significance of Study
Research and data statistics from the National Health and Nutrition Examination
Survey showed that the United States continues to linger in healthcare when it comes to
decreasing the recurrence of bacterial vaginosis. (Koumans et al. , 2007). Data from the
2001-2002 showed bacterial vaginosis to be very common among women of child
bearing ages (Koumans et al., 2007; Allsworth, & Peipert, 2007). Annually in the United
States (U.S.) and Canada the prevalence rates are approximately 4-23% of private
gynecological patients (higher in lower incomes and African American race), 10% to
30% of pregnant women and 12% to 61% of women are seen at clinics for vaginal
discharge or sexually transmitted diseases (Yuden, & Money, 2008). “Research shows
women diagnosed with bacterial vaginosis have an overgrowth of vaginal anaerobes or
Gran – negative bacterial”, (Menard, 2011, p. 295). Research has shown that more than
fifty percent of women diagnosed with bacterial vaginosis are asymptomatic (Donders,
2010; Menard, 2011). Microbiological diagnostic testing method is necessary, such as
Nugent’s scoring system, which is considered the gold standard for diagnosis of having
bacterial vaginosis (Donders, 2010; Menard, 2011). According to the CDC 2012 many
women diagnosed with bacterial vaginosis often have complaints of having a malodorous
discharge, pain with intercourse, itching, and/or burning (CDC, 2012; Menard, 2011).
Untreated bacterial vaginosis can lead to several unfavorable patient outcomes such as
increased risk of sexually transmitted infections (HIV, Chlamydia, Gonorrhea, and
herpes), preterm labor, and premature infants or births (Menard, 2011; CDC, 2012;
Koumans et al, 2007; Allsworth, & Peipert, 2007)
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Project Rationale
Providers have voiced concerns about seeing patients multiple times for recurrent
bacterial vaginosis. At the end of each patient’s health visit they are given an approved
handout from the health clinic, clinician or health educator. Many patients seen at the
health centers have been diagnosed and treated several times for recurrent bacterial
vaginosis. Many patients have voiced concerns as to receiving written materials but no
one has educated them verbally on ways to decrease or change behavioral practices that
increase their risk for acquiring bacterial vaginosis. Written and verbal instructions
remain to be two of the most common forms of communication when relaying drug
information to patients (Pharm, Pierce, & Muhlbaier, 2013). Research has proven that
many “patients don’t understand the written instructions given to them with their
prescriptions” (Pharm, Pierce, & Muhlbaier, 2013, p 1).

There are several reasons cited

by the patients for recurrence such as non-adherence to treatment regimens and/or
behavioral practices. In 2011, Brown, & Bussell reported that 50 percent of patients don’t
take their medications as ordered.

Project Purpose
The purpose of the project was to evaluate patients’ knowledge regarding
bacterial vaginosis prevention, treatment regimens, and attempt to increase patients’
knowledge as a result of training of nurse practitioners and health educators.
Specifically, it was hypothesized that there would be a greater reduction in risk behaviors
related to bacterial vaginosis (increased condom use, reduced wearing of thongs, less
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frequent douching, less use of scented tampons or pads) and more consistent adherence to
the medication regimens in women whose providers received an additional in-service.
Several studies have been conducted relating to ways to increase adherence to treatment
regimens. Today just about everyone has access to computers, cell phones or the internet.
In 2014 Lunny and colleagues concluded that text messaging can play a substantial
important role in notifying patients of doctors’ appointments, STI retesting, provisions of
STI results, and help improve and facilitate patient communication among patients and
health care providers. In 2006, the Institute of Medicine (IOM) wrote a report
emphasizing the importance of educating patients regarding the importance of adhering
to their prescribe regimen. Annually approximately 1.5 million people are affected by
adverse effects of medications simply due to misunderstanding drug information and the
importance of adherence to treatment regimens (Pharm et al., 2011). A statement issued
by the World Health Organization (WHO) in 2003, characterized poor adherence to
treatment as a worldwide problem affecting developing, as well as developed countries
(Brown, & Bussell, 2011). It is estimated that one third to one half of patients are not
taking their medications as prescribed (Kirpalani, Yaom, & Hayes, 2007; Haynes, .et al,
2005). Annually, the US loses approximately $100-$289 billion due to patients being
non-adherent to medication (Ho, 2009; Levine, 2013). World Health Organization
considers adherence to be the single modifiable factor that compromises treatment
outcomes across diseases (Brown, & Bussell, 2011; Au-Yeung, 2011). Patients have
shared several reasons to their health care providers for not taking, adhering to or
completing prescribed medications, including“(1) forgetfulness (30%), (2) other priorities

Increasing Patients’ Knowledge

Garner, Debra, 2014, UMSL, 12.

(16%), (3) deliberate decision to omit doses (11%), (4) lack of information (9%), and (5)
emotional factors (7%)” (Au-Yeung, 2011, p 277).
Review of Literature
This section included a comprehensive review of the literature related to treating
bacterial vaginosis and medication adherence. A literature search was done with multiple
search engines that included full texted articles from Cumulative Index of Nursing and
Allied Health Literature (CINAHL), OVID, and MEDLINE. Key words used in the
literature search included etiology, bacterial, vaginosis, treatment, metronidazole,
clindamycin, adherence, and recurrence. No restrictions were given to dates; all articles
were written in English and published in peer reviewed journals.
Etiology of Bacterial Vaginosis
The cause of bacterial vaginosis continues to raise questions and remains to be
poorly understood (Marrazzo, Thomas, Fiedler, Ringwood, & Fredricks, 2010; Chen et
al., 2009; Koumans et al., 2007; Menard, 2011; CDC, 2012). Bacterial vaginosis is a
synergistic infection involving multiple bacteria. (Marrazzo et al., 2010: Menard, 2011).
Patients diagnosed with bacterial vaginosis commonly have complaints of malodorous
discharge and an increase in vaginal pH flora (Koumans et al., 2007, Elkins, & Mayeaux,
2010.) The exact reason for the rise in the pH remains a mystery to researchers (Kumer
et al., 2011). The vagina continues to be a complex system making women prone to
bacterial vaginosis (Kumer et al., 2011). Many researchers have classified bacterial
vaginosis as a sexually transmitted infection (Turovskiy, Sutyak, & Chikindas, 2011,
Menard, 2011; Cherps, Hillier, Meyn, Busch & Krohn, 2008). Socioeconomic status,
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multiple sex partners, same sex relationships, douching, smoking, medications, and lack
of condom use are several factors which predispose women to bacterial vaginosis
(Klebanoff et al., 2010; Koumans, et al., 2007; CDC, 2012; Menard, 2011).
Diagnosis of Bacterial Vaginosis
The diagnosis of bacterial vaginosis is made if three of four of the following
symptoms known as Amsel’s criteria are present: “a thin homogenous vaginal discharge,
vaginal pH greater than 4.5, fishy amine odor when vaginal discharge is mixed with a
10% potassium hydroxide solution (a positive whiff test), and presence of clue cells
which are epithelial cells with Gram negative polymorphic-bacterial rods attached to their
surface on microscopic examination” (Menard, 2011, p 297; Donders, 2010; Nugent,
Krohn & Hillier, 1992). Bacterial vaginosis can be asymptomatic in about 50% of
women, and for that reason microbiological diagnostic method is necessary, such as
Nugent’s scoring system (Menard, 2011; Donders, 2010; Nugent, et al., 1992). Bacterial
vaginosis is diagnosed using a score applied to gram stains of vaginal fluid and the
Nugent criteria or scoring system. The gold standard for microscopic evaluation of
vaginal discharge for the diagnosis of bacterial vaginosis is Nugent’s scoring system.
(Nugent et al., 1992, Elkins, & Mayeaux, 2010). Menard (2011, p 297) stated there must
be a certain number of lactobacilli and associated bacterial morphotypes required to
create a scale of clear abnormality ranging from normal (score = 0 to 3) through
intermediate (score = 4 to 6) to frank bacterial vaginosis (score = 7 to 10)”. Nugent’s
scoring system must equal 7 or greater for the diagnosis of bacterial vaginosis to be given
(Menard, 2011).
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Treatment Regimens Antibiotic Therapy
This review of the literature continues found that currently, intra-vaginal and oral
formulations of the antibiotics clindamycin and metronidazole continues to be the
recommended formulations for the treatment of bacterial vaginosis (Chen et al., 2009;
Bradshaw, Morton, & Hocking, 2006; Menard, 2011; CDC, 2012). However, oral
metronidazole remains the drug of choice among clinicians and the CDC due to its
efficacy (CDC, 2012). However, most practitioners are aware of the common
gastrointestinal side effects when prescribing systemic metronidazole (CDC, 2012).
Metronidazole Treatment
Since the early 1980s, metronidazole has been used widely in the treatment of
bacterial vaginosis with good clinical results. The CDC has recommended metronidazole
as the first line of treatment for bacterial vaginosis (CDC, 2012: Menard, 2011).
Metronidazole is the drug of choice among clinicians and recommended by the CDC
protozoa infections and other aerobic infections (Lofmark, Edlund, & Nord, 2010). Oral
and vaginal preparations of Metronidazole and Clindamycin have been studied
extensively for the treatment of bacterial vaginosis (Chen et al., 2009; Menard, 2011;
Bunge, Beigi, Meyn, & Hiller, 2009).
Hanson et al., 2000 and Ransom et al., 1999, compared the efficacy of oral
metronidazole (500 mg) take by mouth twice daily and vaginal metronidazole gel 5
grams 0.75 % , both studies showed the treatments to be similar with vaginal preparation
to have fewer side effects than oral treatments regimens. Hanson et al., 2000 & Menard,
2011 studies discussed the criteria for what defines cure and treatment failures for
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bacterial vaginosis. Several studies have shown that 31% of patients treated with vaginal
preparations for bacterial vaginosis have fever gastrointestinal side effects compared to
52 % or oral treatment regimens (Hanson, et al., 2000, Menard, 2011).
The cure rate for the treatment using clindamycin and metronidazole (Flagyl) has
been shown to achieve cure rates of 91-92 % in cases after two weeks of treatment
(Oduyebo et al., 2009). In 2007 Schwebe and colleagues discovered that treatment
utilizing 2 gram of metronidazole for the treatment of bacterial vaginosis had the lowest
cure rates and is no longer recommended. A more recent review also concluded that the
“seven day regimen of metronidazole is superior to the single dose regimen leading
authors to recommend it as the first line regimen in the treatment of bacterial vaginosis”
(Menard, 2011, p 297). Metallic taste, gastrointestinal symptoms nausea, vomiting and
candida infections have been associated with the use of oral metronidazole (CDC, 2012;
Menard, 2011; Oduyebo, Anorlu, Ogunsola, 2009). Vaginal preparations of
metronidazole (Metro gel) have fewer side effects than oral metronidazole (Menard,
2011).
Clindamycin Treatment
The second line of antimicrobial medication used for the treatment of bacterial
vaginosis is Clindamycin (Faro & Skokos, 2005; Menard, 2011). Clindamycin regimens
have several preparations for the treatment of bacterial vaginosis including oral and
vaginal preparations (cream and ovules) (Faro & Skokos, 2005; Menard, 2011). Only one
study was found that evaluated the use of oral clindamycin versus vaginal clindamycin.
Treatment using oral clindamycin of 450 mg three times a day and vaginal clindamycin
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cream had similar cure rates (Faro & Skokos, 2005). In a recent Cochrane review five
gram 2% clindamycin vaginal cream (5 gr) at bedtime for seven days; 100 milligram
(mg) ovule daily for three days or 500 mg oral clindamycin twice daily for seven days
appears to have equivalent efficacy to 500 mg oral clindamycin twice daily for seven
days or topical five gram 0.75% metronidazole gel daily for seven days (Oduyebo et al.,
2009, p). However, topical clindamycin tends to cause lower adverse effects (metallic
taste in the mouth, nausea, and vomiting), than oral metronidazole (Menard, 2011).
Clindamycin creams and ovules are oil based which interferes with condom and
diaphragm safety (Menard, 2011).
Recurrence of Bacterial Vaginosis
Several studies have shown that relapse is frequent after antibiotic therapy (Chen
et al., 2009; Reichman, et al. 2010; Bunge, et al., 2009). The treatment of asymptomatic
women or their sexual contacts will not reduce the transmission of bacterial vaginosis and
is not currently recommended (CDC, 2012; Menard, 2011). The recurrence rate of
bacterial vaginosis can be as high as 30% in 3 months to 58% 12 months after oral
metronidazole therapy in some cases (Reichman et al., 2010; Chen et al, 2009, Menard,
2011). Several reasons were cited for treatment failure using oral metronidazole: (a)
“resistance to the drug of choice, (b) survival of bacteria on the vaginal epithelium (c)
possible re-infection from not abstaining from sex or using condoms during treatment”
(Menard, 2011, p. 302-303). Kirpalani et al., (2007) the rate of non- adherence of patients
not complying with treatment regimens may has been estimated to be 20% to 50 %. Nonadherence can lead to increase hospitalizations, antibiotic resistance, worsening of
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diseases, and health care cost (Osterberg & Blaschkle, 2005). Adherence or compliance
has been called “the key mediator between medical practice and patient outcomes”
(Kirpalani et al. 2007, p. 540). Increasing communication between patients and health
care professionals with simple interventions have been discussed to improve patient
adherence (Kirpalani et al., 2007). In a recent Cochran review database, several simple
interventions appeared to improve adherence with short term regimens (Kirpalani et al.,
2007). Several measures or interventions such as pill counting, electronic pill bottle caps,
and patient diaries to improve medication use for chronic conditions have been studied
and appear to be less effective (Kirpalani et al., 2007). Several studies have been
conducted regarding barriers related to patients adhering to medication treatment
regimens and HIV antiviral treatment adherence (Brown, & Bussell, 2011; Russell, et al.,
2007; Flaks et. al 2003). The transmission of HIV continues to be a worldwide epidemic
(Mayer et al, 2012). Despite education and highly active antiviral HIV and AIDS
treatment (HAART), which has been shown to decrease or slow the spread of HIV by
decreasing the infectiousness of those treated , the spread of HIV in the US alone has
remained unchanged during the past decade ( Mayer , 2012). HIV treatment calls for
strict adherence to antiviral medications. Non-adherence to antiviral medications can
lead to many unfavorable out comes. Research has shown that text messaging can play a
role in notifying patients of doctors’ appointments, STI retesting, provisions of STI
results, and help improve and facilitate patient communication among patients and health
care providers (Lunny et al., 2014).
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Methods
A quasi-experimental approach was utilized using a comparative change model at
two different Planned Parenthood health centers. The project was conducted Monday
through Saturday until the total number of participants reached 50. The project enrolled
50 women, ages 18-45 seen for vaginal discharge and given a diagnosis of bacterial
vaginosis with the ICD 9 code 616. The control group: Clinic A enrolled 25 women,
aged 18-45 of child bearing ages, seen for vaginal discharge and given a diagnosis of
bacterial vaginosis with the ICD 9 code 616. These women were seen by providers and
educators who had not received a 45-minute in-service training that covered information
about behavior change related to type of underwear worn, type of tampons/pads worn,
condom use, and medication adherence. The intervention group: Clinic B enrolled 25
women, aged 18-45 of child bearing ages, seen for vaginal discharge and given a
diagnosis of bacterial vaginosis with the ICD 9 code 616. These women were seen by
providers and educators who had received a 45-minute in-service training that covered
information about behavior change related to type of underwear worn, type of
tampons/pads worn, condom use, and medication adherence. One clinic was randomly
selected for providers to receive the 45 minute in-service training, and the other clinic’s
providers did not receive the in-service training. Subjects were asked to complete two
surveys. The first survey was administered after their diagnosis for bacterial vaginosis
and consent obtained (Appendix A). The initial survey consisted of six questions which
took no longer than 3-4 minutes to complete (Appendix B). Nine to 14 days after the
initial visit a second survey was administered by phone by the researcher. The second
survey took less than 10 minutes and asked about medication adherence and the same
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behavioral changes as survey one (Appendix C). All project material was kept under lock
and key in the health center’s managers’ office. Approximately two weeks into the
project the primary investigator followed up with health center personnel for any
questions and concerns regarding the project. Data was entered and analyzed using the
SPSS program. Data was presented as frequency and percent for categorical variables and
mean and standard deviation (or median and interquartile range where appropriate) and
range (minimum –maximum) for continuous variables. Data was checked for normal
distribution using the Kolmogorov-Smirnov (K-S) Test and visually examined
histograms which revealed that all the continuous variables were skewed.
Eligibility Criteria
Participants between the ages of 18 and 45; who had vaginal discharge; must not
had been treated for bacterial vaginosis within the last month or be currently under
treatment for bacterial vaginosis or taking any antibiotics; were not pregnant; were not
allergic to the treatment medications; and could read and speak English were eligible to
be in the study.

Stakeholders
The stakeholders for this pilot project consisted of patients, health center
clinicians, educators and insurance companies. The World Health Organization (WHO)
has adopted different views as to what constitutes a disparity. Ethnicity, sex and quality
of and/or access to care when treating patients were several disparities discussed by the
World Health organization (American College of Physicians, 2010). Major stakeholders
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such as health care providers and insurance companies agreed that such disparities are
unjust and need to be addressed by (American College of Physicians, 2010). Medical and
clinical outcomes were affected by all of the stakeholders involved when treating
bacterial vaginosis. Increased health care cost, death and worsening of disease have been
attributed to non-adherence of medication treatment regimens (Osterberg & Blaschkle,
2005). All stake holders were important in increasing patient knowledge regarding the
transmission of bacterial vaginosis and its treatment regimens. Advanced Practice Nurses
provided evidence based treatment regimens and education to the patients they serve.
Accountably is ultimately up to patients to adhere to medication and treatment regimens
(Osterberg, & Blaschkle, 2005). As stated by the former Surgeon General C. Everett
Koop “drugs don’t work if patients don’t take them” (Osterberg, & Blaschkle, 2005, p
487). When patients adhere to medication regimens patients are healthier and there is a
decrease in hospital costs and admissions.
Challenges to Project
The challenges to the project were the small sample size and conducting the
project only within two Midwest Health Care Centers. Lower social economic status
and/or population, educational level, age and race were additional challenges to the
project. Other challenges the project faced when measuring outcomes included the use
of female feminine products (pads or tampons), the association of bacterial vaginosis
with birth control methods, types of underwear (cotton or silk), and menstrual cycles
(Klebanoff et al., 2010; Menard, 2011: Koumans et al., 2007). Another challenge
included data collected through self- report and patients possibly not being truthful with
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the providers regarding taking their medications or their sexual and hygiene behaviors.
Several rationales to results obtained from the project may be related to (1) Are the
clinicians and health educators using pre/post questionnaires the same way all the time?
(2) Are all clinicians and health educators receiving the same education and are they
educating their patients in similar ways? (3) How will new employees be educated? (4)
How will the investigator track the movement of employees within the establishments?

Application to Practice
The results of this project will be disseminated and discussed with the Advanced
Practice Nurses and health center directors involved in the project. This project will be
helpful for the Advanced Practice Nurses when discussing drug regimens and plans of
care by increasing the patients’ knowledge and education regarding the transmission of
bacterial vaginosis. This project encouraged positive changes by both the providers and
patients by using evidence based discharge sessions. Behavioral changes made by the
patients involved in the study will inevitably increase medication adherence and decrease
the risk of acquiring bacterial vaginosis. This clinical project had an inter-professional
collaboration among providers APRNs and stake holders by using evidence based
practice and education which helped increase patient’s knowledge regarding bacterial
vaginosis and its treatment regimens.
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Theoretical Framework
Many people are apprehensive to change. However, change can bring out the best
in individuals. There were many ways of implementing change throughout this clinic
project. Kurt Lewins’ theoretical framework ‘Change Theory” guided this clinical
project. Schifalacqua et al. (2009) and his colleagues state that Lewins’ changed method
will be adapted, when there is a plan, a purpose, and collaboration among those involved.
Lewin’s Change theory addressed how and why change occurs. In 1951 Kurt Lewin
explained that in order for change to take place there are three steps the agent must go
through (Figure 1).

Fig.1 Lewin's Theory of Change
Unfreezing was the 1st step: change was needed. The advanced nurse practitioners
and health center educators were in-serviced on up to date evidence based practices on
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bacterial vaginosis. In the unfreezing phase the advanced practice nurse and health center
educators challenged patients beliefs (“scented tampons or pads”) will make sure I won’t
have a vaginal odor while on my menses”), attitudes (“I don’t have to use condoms 100
%”) and norms “(it’s normal to douche; everyone douches after their menstrual cycle”).
Moving/Change is the second step of the Change Theory: change had been initiated. In
order for the change to be successful patients believed change was needed. Advanced
nurse practitioners and health center educators reevaluated their teaching by giving
patients a post questionnaire by phone call between days 9-14 after their initial visits.
Medical providers educated patients on ways to decrease or minimize their risk on
acquiring bacterial vaginosis ex. (a) increasing condom usage (b) reducing the use of
scented feminine products during their menstrual cycles, (c) decreasing douching and (d)
increasing the percentage of wearing cotton underwear throughout the month. Refreezing
took place after equilibrium had been established, which was the last phase or step to the
Change Theory. Patients understood with behavioral changes such as no douching, no
thongs or non-cotton type underwear, 100% usage of condoms, and 100% compliance
with medication would decrease their risk of acquiring or having a recurrence of bacterial
vaginosis.
Gaps in Nursing Science
As discussed by Marrazzo, et al. (2010, p. 740) there were several outstanding
questions that warrant further investigation: (a) “What is normal clinically,
microbiologically, and immunologically? (b) What was considered normal for the human
vagina? (c) Which bacterial or bacterial community types were associated with bacterial
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vaginosis?” A major limitation of several studies of the vaginal microbiota is their failure
to use any objective method such as Amsel’s or Nugent criteria to assess for bacterial
vaginosis (Marrazzo et al., 2010). No studies or reviews were found that discussed
medication adherence when treating bacterial vaginosis. However, there were several
studies regarding medication adherence when treating HIV, chlamydia and gonorrhea
infections (Lunny et al, 2014). There appeared to be gaps in nursing research regarding
compliance when treating bacterial vaginosis.
Research Question
The research question to be answered was there a greater increase in patients’
knowledge and behaviors in the intervention group regarding bacterial vaginosis and
medication adherence, as compared to the comparison group?

Project Design
Instruments /Tool Development
There are no programs at the present to follow, therefore an appropriate
instrument to measure clinicians and patients’ knowledge was adapted and modified to
questions by the lead investigator. Medication adherence was measured using a
questionnaire modified by the primary investigator, Patients’ Medication Adherence
Questionnaire (see Appendix D). All surveys developed were written on at or below
fourth grade level. The medication adherence questionnaire was modified to be
appropriately used with the project for timing of data collection and constraints to the
project. Validity was assessed by making sure all goals and objectives were clearly
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defined. Staff members were surveyed and asked to look over the questionnaires for
troublesome wording, readability and/or understanding, comments, concerns and/or
suggestions.
Data Analysis
A total of 50 women participated in the study which included pretest, posttest, and
adherence questions analyzed at first with Univariate analysis. Data were presented as
frequency and percent for categorical variables and mean and standard deviation (or
median and interquartile range where appropriate) and range (minimum –maximum) for
continuous variables. Data were checked for normal distribution using the KolmogorovSmirnov (K-S) Test and visually examining histograms which revealed that all the
continuous variables were skewed. Thus the Mann Whitney test, ranks data from low to
high, rather than using exact values, was used instead of the independent samples t-test.
The group with the highest mean rank has the highest scores and vice versa. The median
measure was used for the adherence score given the skewed nature as indicated by the
significant K-S test. A p-value of 0.05 was considered statistically significant. Since only
5% of the study participants had menstrual cycles since their last visit, not enough data
was available to analyze usage of scented feminine products. Since 30% of the study
population reported sexual activity since their last visit, not enough data was available to
analyze condom usage. The distribution of adherence score is the same across categories
of the intervention using the Mann-Whitney U Test (non-parametric equivalent of the
Students t-test). All data was analyzed using SPSS statistical package (version 20.0,
SPSS Inc., Chicago, IL, USA).
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Table 1. Pre-Test Univariate Analysis by Intervention Status (n=50)
Contro
l
Question
(n=25)
In the Past 3 months how often have you used condoms?
Always
Sometimes
Never
Last time you had sex did you use condoms? (yes)
During last menstrual cycle did you use any scented feminine
tampons or pads? (yes)

Interventio
n
(n=25)

3(12)
10(40)
12(48)
6(24)

4(16)
7(28)
13(52)
7(28)

6(24)

3(12)

In last 30 days, how many days did you wear thong underwear? †
Range (days)

0(0)
0-20

0(0)
0-15

In last 30 days, how many days did you wear cotton underwear? †
Range (days)
In last 30 days, how many days did you douche? †
Range
Results are presented as Frequency and Percent unless denoted.
† Results presented as median and interquartile range.

30(0)
10-30
0(0)
0-3

30(2)
15-30
0(1.50)
0-4
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Table 2. Post-Test Univariate Analysis by Intervention Status (n=50). All Questions
pertain to the last 9-14 Days
Control Intervention
Question
(n=25)
(n=25)
Have you had sex since your visit to the health clinic? (yes)
6(24)
8(38)
How many times?
2.00(2.50) 2.00(0.50)
Range (days)
1-4
2-4
How often did you use a condom?
Always
1(17)
2(29)
Sometimes
3(50)
4(14)
Never
2(33)
1(14)
Have you had a menstrual cycle? (yes)
1(4)
2(8)
Did you use any scented feminine tampons or pads? (yes)
1(100)
0(0)
†
How many days have you worn thong underwear?
0(0)
0(0)
Range (days)
0-9
0-2
†
How many days have you worn cotton underwear?
9(0)
9(0)
Range (days)
0-9
7-9
Have you douched since your last visit to the health clinic?
(yes)
1(5)
4(20)
†
How many times have you douched?
0(0)
0(0)
Range (days)
0-2
0-2
Results are presented as Frequency and Percent unless denoted.
† Results presented as median and interquartile range. Adherence of wearing thong and
cotton underwear was assessed using Fisher’s Exact Test. Numbers do not add up to 50
due to loss at follow up.
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Table 3. Post-Test Adherence Univariate Analysis by Intervention
Status (n=45).
Control Intervention
Question
(n=20)
(n=25)
In the last 9-14 days since your visit to health
center have you forgotten to take your Flagyl or
Metro gel? (yes)
16(64)
6(24)
Over the past 7 days, were there any days when
you did not take your Flagyl or Metro Gel
Medicine?(yes)
16(64)
6(24)
Have you ever stopped or cutback on taking your
Flagyl or Metro Gel without telling your
healthcare provider because it made you feel
worse? (yes)
25(100)
17(71)
Did you take all of your doses of Flagyl or Metro
Gel yesterday? (yes)
22(88)
23(92)
When you feel like your symptoms are under
control, do you sometimes stop taking your Flagyl
or Metro Gel medicine? (yes)
25(100)
19(79)
Do you sometimes feel hassled about sticking to
your treatment plan? (yes)
25(100)
20(83)
How often do you have difficulty remembering to
take all of your Flagyl or Metro Gel?
Never/Rarely
0(0)
4(17)
Once in a while
4(16)
6(25)
Sometimes
10(40)
7(29)
Usually
6(24)
3(13)
All the time
5(20)
4(17)
† (median, SD, max, min)
Total Score
7(2)
5(3)*
Range (points)
5-7
0-7
Low Adherence
25(100)
19(76)**
Results are presented as Frequency and Percent unless denoted.
† Results presented as median and interquartile range.
Number does not equal 50 due to 5 participants were lost due to follow up.
Control Group (median = 7.00, SD = .943, Min = 5, max = 7, p < .002)
Intervention Group ( median =5.00, SD = 2.219, min = 0, max = 7, p > .035)
*p-value for Mann-Whitney U < .002
**p-value for chi-square = .035
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Results
The control group showed a lower range on three of the questions relating to
wearing of cotton or thong underwear and douching before in-servicing was provided to
the intervention group of Advanced Nurse Practitioners and health care providers (see
table #1).

The intervention group had a lower median adherence score as calculated in the
Mann-Whitney U test, compared to the control group (p<.002). The intervention group
had better adherence to their Flagyl and Metro Gel medication. The median measure was
used for the adherence score given the skewed nature as indicated by the significant K-S
test. A p-value of 0.05 was considered statistically significant (see table #3).

Adherence of wearing thong and cotton underwear was assessed as a yes/no
variable by intervention status; differences between the two groups were assessed using
Fisher’s Exact Test instead of Pearson’s Chi-Square given small cell size. There was no
significant difference between the intervention and control group (p>0.05) in regards to
wearing of thong or cotton underwear (see table #2).

Only 5% of the study participants reporting having had a menstrual cycle since
their last visit, not enough data were available to analyze usage of scented feminine
products. With only 30% of the study population reporting sexual activity since their last
visit, not enough data was available to analyze condom usage.
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Post- Test Adherence Intervention Status

Data analysis of the adherence was analyzed by their clinic allocation (intent to
treat analysis) following analysis of the post -test adherence, seven of the nine questions
retained to the primary investigators null hypothesis that there would be a greater effect
on the intervention group receiving education from health care providers. The analysis of
the total score and low adherence between the control and intervention group reject the
null hypothesis were evaluated with Mann-Whitney U and chi-square, respectively, with
as both have a p value <.05 (p < .002 and p =.035, respectively). The median adherence
score for the control group was 7, and the median adherence score for the intervention
group was 5.00. Since lower scored indicate better adherence, the intervention group
adhered significantly more than the control group.

Conclusion
The project showed that after an educational in-service with the Advanced
Practice Nurses and health educators there was an increase in patients’ knowledge
regarding the transmission of bacterial vaginosis and adherence to treatment regimens, as
compared to the control group, whose providers had not received the in-service. The lead
investigator will disseminate the findings to the medical director, lead clinician, and
health center staff. The findings of the study will be submitted as a poster presentation at
the national Family Planning conference. This project can be replicated in the other
family planning facilities or similar health centers by in-servicing the health care
providers and educators on current evidence based practice, developing protocols for
treatment of bacterial vaginosis and educating patients’ on behaviors associated with
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increased chances of contracting bacterial vaginosis. Increasing clinician and patient
knowledge regarding bacterial vaginosis, behavioral changes, and medication adherence
were important key factors for the success of this project.

Essentials to DNP Practice
The development of a professional doctorate program for nursing has been in the
works for decades (Chism, 2010). Many have raised the question since the development
of the DNP program, what exactly is the Doctor of Nursing Practice (DNP) degree?
(Chism, 2010). As stated by Chism (2010) the “Doctoral education in nursing is
connected to our past and influences the directions we may take in the future”, (Chism,
2010 p. 3). Doctoral prepared clinicians will be better prepared to handle the more
critically ill and underrepresented patients and provide higher quality care utilizing
evidence based measures. As nurse practitioners further their education and clinical
practice, they will help to bring such process bring about positive changes in health status
which affects practice and education at the doctoral level. Such positive changes help to
increase patients’ knowledge regarding behavioral and changes to help decrease their risk
of acquiring bacterial vaginosis and improving medication adherence. The DNP
essentials used to guide this project were the “Scientific Underpinnings for Practice and
Inter-professional Collaboration for Improving Patient and Population Health Outcomes
and Clinical Scholarship and Analytic Methods for Evidence –Based Practice (Chism,
2010). DNP Essential I, Scientific Underpinnings for Practice and Inter-professional
Collaboration for Improving Patient and Population Health Outcomes were met by
collaboration among the primary investigator and other health clinicians to help patients
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improve medication adherence when treating bacterial vaginosis and identifying
behavioral changes to decrease the risk of acquiring bacterial vaginosis. DNP Essential
III was met by incorporating evidence based literature and discharge instructions to
patients and in-servicing health care providers on up to date treatment regimens. The
project main goals were met by increasing medication adherence and encouraging
positive behavioral changes by patients.
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Appendix A

Consent Form
Study Title:

Increasing Patients Knowledge in Transmission of
Bacterial Vaginosis and its Treatment Regimens

Principal Investigator:

Debra Pikes, BC-FNP

Address:

Planned Parenthood

Planned Parenthood

West County Health Center

North County

Stonegate Center #1

2796-98 N. Hwy 67

Manchester, MO 63088

Florissant, Mo. 63033

Introduction: You are being asked to participate in this clinical project to assess
patient’s knowledge regarding bacterial vaginosis and medication adherence. After
reading this form, you can decide to be in the project or you can decide not to be in the
project. Either choice is OK.
Participants Status: This project is strictly voluntary and I may stop participation at any
time.
Study Goals: The project will evaluate patients’ knowledge regarding behavioral
changes and adherence to medications when treating bacterial vaginosis.
Sample collection: Collection of vaginal discharge using a clean unlubricated speculum
and evaluation of vaginal discharge by microscope will be performed by a trained nurse
practitioner.
Procedures: All patients participating in the project will be asked to complete a pre and
post questionnaire regarding their knowledge pertaining to behavioral practice, treatment
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regimens of bacterial vaginosis and medications prescribed. Patients will be followed up
with a phone call at approximately 9-14 days after their visit.
Confidentiality Pledge: All information will be kept confidential and only shared with
those involved in analyzing the questionnaires, Midwest Health Centers Directors and
Advanced Nurse Practitioners and the University of Missouri Committee members. The
Electronic medical records will be accessed only to retrieved data for the project. All
project participants will be identified by their medical record number.
Compensation: I agree that if I participate in this project I will not be compensated for
my time.
Potential Risk: The potential risk involved in this project may be discomfort while
receiving a pelvic exam, increase risk for infection or potential false positive test results.
Participant Selection: If you agree to take party in this project, you will be one of about
50 subjects taking part at two family planning clinics. To be included in this project, you
must currently have vaginal discharge; must be at least 18 years of age but no older than
45 years old, must not have been treated for bacterial vaginosis within the last month or
currently under treatment or taking any antibiotics, not pregnant, allergic to the treatment
medications, able to read and speak English.
Contact Information: If at any time during this study you have any questions or
concerns the investigator may be reached at: DP469@umsl.edu
_____________________________

________________________

Subject Signature

Date

_____________________________

_________________________

Signature of Witness/Investigator

Date
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Appendix B
Bacterial Vaginosis Pre-Questionnaire
MRN_________________________ Date of Service_________________
1. In the past 3 months how often have you used condoms?
(a) always

(b) sometimes

(c) never

2. Last time you had sex did you use condoms?
(a) yes

(b) no

3. During your last menstrual cycle did you use any scented feminine tampons or
pads?

(a) yes

(b) no

4. In the last thirty (30) days, how many days did you wear thong underwear?
5. In the last thirty (30) days, how many days did you wear cotton underwear?
6. In the last thirty (30) days, how many times did you douche?
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Appendix C
Bacterial Vaginosis Questionnaire
MRN_________________________ Date of Service______________________
Post follow up date __________________
1. In the last 9-14 days have you has sex since your visit to the health clinic?
(a)yes

(b) no

2. If yes, how many times? And how often have you used condoms with sex?
(a) always

(b) sometimes (c) never

3. In the last 9-14 days have you had a menstrual cycle?
(a) Yes

(b) no

4. If yes, did you use any scented feminine tampons or pads?
(a) yes

(b) no

5. In the last 9-14 days since your visit to the health clinic how many days have
you worn thong underwear?
6. In the last 9-14 days since your visit to the health clinic how many days have
you worn cotton underwear?
7. In the last 9-14 days have you douched since your visit to the health clinic?
(a) yes

(b) no

8. If yes, how many times have you douched?
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Appendix D
MRN____________________
Patient Post medication Questionnaire___________________
Date of Follow up_________________________
Question

Patient Answer
(Yes / No)

Score
Y=1 N=0

1. In the last 9-14 days since your visit to the health center have you forgotten to
take your Flagyl or Metro gel medication?
Yes / No
2. People sometimes miss taking their medicines for reasons other than forgetting.
Thinking over the past 7 days, were there any days when you did not take your
Flagyl or Metro Gel medicine?
Yes/ No
3. Have you ever stopped or cut back on taking your Flagyl or Metro Gel medication
without telling your health care provider because it made you feel worse?
Yes/No
4. Did you take all of your doses of Flagyl or Metro Gel yesterday?
Yes/No
5. When you feel like your symptoms are under control, do you sometimes stop
taking your Flagyl or Metro Gel medicine?
Yes/No
6. At times taking medication can be a real inconvenience for some people. Do you
sometimes feel hassled about sticking to your treatment plan?
Yes /No
7. How often do you have difficulty remembering to take all of your Flagyl or Metro
Gel?
A=0
B-E=1
___ A. Never/rarely
__ B. Once in a while
__ C. Sometimes
__ D. Usually
__ E. All the time
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Total Score: Scores: >2 = low adherence 1 or 2 = medium adherence 0 = high
adherence

